(Reuters) - A new drug to treat a breathing disorder that is the leading cause of death of premature babies cleared a regulatory hurdle, allowing Discovery Laboratories Inc to release it in the United States before the end of the year. Discovery, whose shares rose 55 percent on Friday, is entitled to about $20 million in loans from Deerfield Management Co LP if it launches the drug, Surfaxin, this year. The drug was approved by the U.S. ... via Health News Headlines - Yahoo! News Read More Here..
Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/10/discovery-labs-shares-soar-after_4.html
No comments:
Post a Comment